On the Mechanism of Hyperthermia-Induced BRCA2 Protein Degradation

Division of Cancer Sciences, Faculty of Biology, Medicine and Health, Manchester Cancer Research Centre, University of Manchester, Manchester M20 4GJ, UK

⁴

Department of Biochemistry, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands

⁵

Department of Cell Biology and Histology Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands

Author to whom correspondence should be addressed.

Cancers 2019, 11(1), 97; https://doi.org/10.3390/cancers11010097

Received: 18 December 2018 / Revised: 9 January 2019 / Accepted: 10 January 2019 / Published: 15 January 2019

(This article belongs to the Special Issue Hyperthermia-based Anticancer Treatments)

View Full-Text Download PDF

Browse Figures

Review Reports Citation Export

Abstract

The DNA damage response (DDR) is a designation for a number of pathways that protects our DNA from various damaging agents. In normal cells, the DDR is extremely important for maintaining genome integrity, but in cancer cells these mechanisms counteract therapy-induced DNA damage. Inhibition of the DDR could therefore be used to increase the efficacy of anti-cancer treatments. Hyperthermia is an example of such a treatment—it inhibits a sub-pathway of the DDR, called homologous recombination (HR). It does so by inducing proteasomal degradation of BRCA2 —one of the key HR factors. Understanding the precise mechanism that mediates this degradation is important for our understanding of how hyperthermia affects therapy and how homologous recombination and BRCA2 itself function. In addition, mechanistic insight into the process of hyperthermia-induced BRCA2 degradation can yield new therapeutic strategies to enhance the effects of local hyperthermia or to inhibit HR. Here, we investigate the mechanisms driving hyperthermia-induced BRCA2 degradation. We find that BRCA2 degradation is evolutionarily conserved, that BRCA2 stability is dependent on HSP90, that ubiquitin might not be involved in directly targeting BRCA2 for protein degradation via the proteasome, and that BRCA2 degradation might be modulated by oxidative stress and radical scavengers. View Full-Text

Keywords: hyperthermia; homologous recombination; BRCA2; RAD51; ubiquitin; SILAC mass spectrometry; reactive oxygen species; protein degradation; HSP90

▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Share and Cite

MDPI and ACS Style

van den Tempel, N.; Zelensky, A.N.; Odijk, H.; Laffeber, C.; Schmidt, C.K.; Brandsma, I.; Demmers, J.; Krawczyk, P.M.; Kanaar, R. On the Mechanism of Hyperthermia-Induced BRCA2 Protein Degradation. Cancers 2019, 11, 97. https://doi.org/10.3390/cancers11010097

AMA Style

van den Tempel N, Zelensky AN, Odijk H, Laffeber C, Schmidt CK, Brandsma I, Demmers J, Krawczyk PM, Kanaar R. On the Mechanism of Hyperthermia-Induced BRCA2 Protein Degradation. Cancers. 2019; 11(1):97. https://doi.org/10.3390/cancers11010097

Chicago/Turabian Style

van den Tempel, Nathalie, Alex N. Zelensky, Hanny Odijk, Charlie Laffeber, Christine K. Schmidt, Inger Brandsma, Jeroen Demmers, Przemek M. Krawczyk, and Roland Kanaar. 2019. "On the Mechanism of Hyperthermia-Induced BRCA2 Protein Degradation" Cancers 11, no. 1: 97. https://doi.org/10.3390/cancers11010097

Find Other Styles

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Abstract views Pdf views Html views

Article Menu

On the Mechanism of Hyperthermia-Induced BRCA2 Protein Degradation

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Article Access Map by Country/Region

Further Information

Guidelines

MDPI Initiatives

Follow MDPI